Baylor's clinical exome enhances coverage of over 3,600 genes and the lab has also validated Illumina's HiSeq X Ten for its research pipeline.
The Singapore-based molecular diagnostics firm continues to operate under court supervision while its finances get sorted out.
Canaccord upgraded the shares of Quest and LabCorp to Buy following a survey that indicated patients will see their PCPs more often in 2015.
OncoDNA's deal with Spanish personalized cancer genomics firm BioSequence is its ninth such exclusive distribution agreement.
Zykadia received conditional marketing authorization as a treatment for advanced NSCLC patients who've previously received the ALK inhibitor Xalkori, and so are known to be ALK positive.
In PNAS this week: Akt3 amplification in glioma progression, Tibetan Plateau frog genome, and more.
The US Supreme Court has declined to review a decision involving the use of "inadvertently shed" DNA in a police investigation and subsequent conviction.
A panel at the New York Times discusses anonymity and privacy of users of 23andMe's services when access to its database is offered for research.
National Institutes of Health Director Francis Collins appears before a House subcommittee to discuss his agency's budget request.